E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 938.2 ILS 3.33% Market Closed
Market Cap: 276.9m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note

Profitability Summary

Epitomee Medical Ltd's profitability score is 34/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

34/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

34/100
Profitability
Score
34/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Epitomee Medical Ltd

Revenue
10m USD
Operating Expenses
-16.9m USD
Operating Income
-6.9m USD
Other Expenses
912k USD
Net Income
-6m USD

Margins Comparison
Epitomee Medical Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
IL
Epitomee Medical Ltd
TASE:EPIT
276.9m ILS
-69%
-60%
US
Abbott Laboratories
NYSE:ABT
204.9B USD
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
195.2B USD
26%
29%
US
Stryker Corp
NYSE:SYK
146.7B USD
22%
16%
US
Boston Scientific Corp
NYSE:BSX
132.6B USD
18%
11%
IE
Medtronic PLC
NYSE:MDT
110.6B USD
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
64.7B USD
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
55.6B EUR
12%
8%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
319.2B CNY
37%
34%
US
Edwards Lifesciences Corp
NYSE:EW
41.6B USD
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.7B USD
13%
9%
Country IL
Market Cap 276.9m ILS
Operating Margin
-69%
Net Margin
-60%
Country US
Market Cap 204.9B USD
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 195.2B USD
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 146.7B USD
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 132.6B USD
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 110.6B USD
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 64.7B USD
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Operating Margin
12%
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Operating Margin
37%
Net Margin
34%
Country US
Market Cap 41.6B USD
Operating Margin
28%
Net Margin
74%
Country US
Market Cap 37.7B USD
Operating Margin
13%
Net Margin
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Epitomee Medical Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Epitomee Medical Ltd
TASE:EPIT
276.9m ILS
-19%
-14%
-17%
-101%
US
Abbott Laboratories
NYSE:ABT
204.9B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
195.2B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
146.7B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
132.6B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
110.6B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
64.7B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
55.6B EUR
11%
4%
8%
5%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
319.2B CNY
35%
23%
32%
40%
US
Edwards Lifesciences Corp
NYSE:EW
41.6B USD
51%
37%
16%
18%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.7B USD
22%
5%
10%
7%
Country IL
Market Cap 276.9m ILS
ROE
-19%
ROA
-14%
ROCE
-17%
ROIC
-101%
Country US
Market Cap 204.9B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 195.2B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 146.7B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 132.6B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 110.6B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 64.7B USD
ROE
7%
ROA
3%
ROCE
6%
ROIC
5%
Country DE
Market Cap 55.6B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country CN
Market Cap 319.2B CNY
ROE
35%
ROA
23%
ROCE
32%
ROIC
40%
Country US
Market Cap 41.6B USD
ROE
51%
ROA
37%
ROCE
16%
ROIC
18%
Country US
Market Cap 37.7B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top